Cargando…
Endocrine therapies in breast cancer /
Breast cancer is one of the leading causes of cancer mortality in women worldwide, and the risk of disease recurrence continues despite improvements in screening and treatment. For patients with hormone receptor-positive breast cancer, some form of endocrine therapy is central to the management of t...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford ; New York :
Oxford University Press,
2007.
|
| Colección: | Oxford oncology library.
|
| Temas: | |
| Acceso en línea: | Texto completo |
| Sumario: | Breast cancer is one of the leading causes of cancer mortality in women worldwide, and the risk of disease recurrence continues despite improvements in screening and treatment. For patients with hormone receptor-positive breast cancer, some form of endocrine therapy is central to the management of their disease. Tamoxifen has long been the mainstay of endocrine therapy in this group of patients. However, there is mounting evidence showing that the aromatase inhibitors are able toreduce overall oestrogen levels and appear to be better tolerated over a long term than tamoxifen. New and emerging. |
|---|---|
| Descripción Física: | 1 online resource (viii, 120 pages) : illustrations |
| Bibliografía: | Includes bibliographical references and index. |
| ISBN: | 9780191575174 0191575178 0191739871 9780191739873 0199606994 9780199606993 1283580756 9781283580755 9786613893208 661389320X |